Interaction of antivirals with a heptameric bundle model of the p7 protein of hepatitis C virus

A series of ligands are known experimentally to affect the infectivity cycle of the hepatitis C virus. The target protein for the ligands is proposed to be p7, a 63 amino acid polytopic channel-forming protein, with possibly two transmembrane domains. Protein p7 is found to assemble into functional...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dahl, Sophie L. (VerfasserIn) , Kalita, Monoj Mon (VerfasserIn) , Fischer, Wolfgang (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 18 December 2017
In: Chemical biology and drug design
Year: 2017, Jahrgang: 91, Heft: 4, Pages: 942-950
ISSN:1747-0285
DOI:10.1111/cbdd.13162
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1111/cbdd.13162
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/cbdd.13162
Volltext
Verfasserangaben:Sophie L. Dahl, Monoj Mon Kalita, Wolfgang B. Fischer

MARC

LEADER 00000caa a2200000 c 4500
001 1575906341
003 DE-627
005 20230427042919.0
007 cr uuu---uuuuu
008 180601s2017 xx |||||o 00| ||eng c
024 7 |a 10.1111/cbdd.13162  |2 doi 
035 |a (DE-627)1575906341 
035 |a (DE-576)505906341 
035 |a (DE-599)BSZ505906341 
035 |a (OCoLC)1341010433 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Dahl, Sophie L.  |d 1992-  |e VerfasserIn  |0 (DE-588)1160458774  |0 (DE-627)1023638940  |0 (DE-576)505907046  |4 aut 
245 1 0 |a Interaction of antivirals with a heptameric bundle model of the p7 protein of hepatitis C virus  |c Sophie L. Dahl, Monoj Mon Kalita, Wolfgang B. Fischer 
264 1 |c 18 December 2017 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 01.06.2018 
520 |a A series of ligands are known experimentally to affect the infectivity cycle of the hepatitis C virus. The target protein for the ligands is proposed to be p7, a 63 amino acid polytopic channel-forming protein, with possibly two transmembrane domains. Protein p7 is found to assemble into functional oligomers of various sizes, depending on the genotype (GT). Nine ligands are docked to various sites of a computationally derived heptameric bundle of p7 of GT1a. The energy of interaction, here binding energy, is calculated using three different docking programs (Autodock, MOE, LeadIT). Three protein regions are defined to which the ligands are placed, the loop region and the site with the termini as well as the mid-region which is supposed to track poses inside the putative pore. A common feature is that the loop sites and poses either within the pore or at the intermonomer space of the bundle are preferred for all ligands with proposed binding energies smaller than −10 kJ/mol. BIT225, benzamine, amantadine, and NN-DNJ show good overall scoring. 
650 4 |a adamantanes 
650 4 |a guanidinium compounds 
650 4 |a imino-sugars 
650 4 |a p7 of HCV 
650 4 |a viral channel protein 
700 1 |a Kalita, Monoj Mon  |e VerfasserIn  |0 (DE-588)1137643684  |0 (DE-627)895007363  |0 (DE-576)49168374X  |4 aut 
700 1 |a Fischer, Wolfgang  |d 1962-  |e VerfasserIn  |0 (DE-588)1046340182  |0 (DE-627)776113542  |0 (DE-576)170207773  |4 aut 
773 0 8 |i Enthalten in  |t Chemical biology and drug design  |d Oxford : Wiley-Blackwell, 2006  |g 91(2017), 4, Seite 942-950  |h Online-Ressource  |w (DE-627)505951037  |w (DE-600)2216600-2  |w (DE-576)252074947  |x 1747-0285  |7 nnas  |a Interaction of antivirals with a heptameric bundle model of the p7 protein of hepatitis C virus 
773 1 8 |g volume:91  |g year:2017  |g number:4  |g pages:942-950  |g extent:8  |a Interaction of antivirals with a heptameric bundle model of the p7 protein of hepatitis C virus 
856 4 0 |u http://dx.doi.org/10.1111/cbdd.13162  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1111/cbdd.13162  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180601 
993 |a Article 
994 |a 2017 
998 |g 1160458774  |a Dahl, Sophie L.  |m 1160458774:Dahl, Sophie L.  |d 160000  |d 160100  |e 160000PD1160458774  |e 160100PD1160458774  |k 0/160000/  |k 1/160000/160100/  |p 1  |x j 
999 |a KXP-PPN1575906341  |e 3011211167 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"note":["Gesehen am 01.06.2018"],"physDesc":[{"extent":"8 S."}],"relHost":[{"pubHistory":["67.2006 -"],"origin":[{"dateIssuedKey":"2006","publisher":"Wiley-Blackwell ; Blackwell Publ. [[-2008]]","dateIssuedDisp":"2006-","publisherPlace":"Oxford ; Oxford"}],"recId":"505951037","id":{"issn":["1747-0285"],"eki":["505951037"],"zdb":["2216600-2"],"doi":["10.1111/(ISSN)1747-0285"]},"title":[{"title":"Chemical biology and drug design","title_sort":"Chemical biology and drug design"}],"language":["eng"],"disp":"Interaction of antivirals with a heptameric bundle model of the p7 protein of hepatitis C virusChemical biology and drug design","part":{"issue":"4","year":"2017","pages":"942-950","volume":"91","text":"91(2017), 4, Seite 942-950","extent":"8"},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 02.12.10"],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"18 December 2017"}],"title":[{"title_sort":"Interaction of antivirals with a heptameric bundle model of the p7 protein of hepatitis C virus","title":"Interaction of antivirals with a heptameric bundle model of the p7 protein of hepatitis C virus"}],"person":[{"role":"aut","given":"Sophie L.","roleDisplay":"VerfasserIn","display":"Dahl, Sophie L.","family":"Dahl"},{"family":"Kalita","given":"Monoj Mon","roleDisplay":"VerfasserIn","display":"Kalita, Monoj Mon","role":"aut"},{"family":"Fischer","display":"Fischer, Wolfgang","roleDisplay":"VerfasserIn","given":"Wolfgang","role":"aut"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Sophie L. Dahl, Monoj Mon Kalita, Wolfgang B. Fischer"]},"recId":"1575906341","id":{"doi":["10.1111/cbdd.13162"],"eki":["1575906341"]}} 
SRT |a DAHLSOPHIEINTERACTIO1820